A Rare Case of Adenosquamous Carcinoma Arising from Intraductal Papillary Neoplasm of the Bile Duct. [PDF]
Kawahito A +4 more
europepmc +1 more source
Rare Secondary Neoplasms Arising in Epidermal Nevus: A Case Series and Literature Review
ABSTRACT Malignant transformation is known to occur with many nevi, such as nevus sebaceus. However, cases of secondary tumors developing in an epidermal nevus (EN) are rare, with only a few case reports documented in the literature. We present three unique cases of syringocystadenoma papilliferum (SCAP), syringofibroadenoma, trichilemmoma, and basal ...
Haya A. Homsi +5 more
wiley +1 more source
The fascinating history of papillary thyroid carcinoma nuclei: revelation of two nuclear morphologies-"Classical papillary" and "papillary-like", with different pathobiologic characteristics. [PDF]
Ohori NP +3 more
europepmc +1 more source
ABSTRACT Endocrine mucin‐producing sweat gland carcinoma (EMPSGC) is an adnexal neoplasm which typically occurs on periorbital skin and demonstrates overlapping histopathologic features with primary mucinous carcinoma of the skin (MCS). Herein, we report a patient who developed five distinct lesions of EMPSGC and MCS over an eight‐year period, some of ...
Ikuko Hirai +5 more
wiley +1 more source
Discoid Lupus Erythematosus in Genital Skin: A Case Report and Review of the Literature
ABSTRACT Background Discoid lupus erythematosus (DLE) represents the most common variant of chronic cutaneous lupus erythematosus, a skin‐specific autoimmune disorder within the broader lupus erythematosus spectrum Clinically, DLE is characterized by erythematous, scaly plaques with areas of hyperpigmentation.
Ala' Abu‐Dayeh +2 more
wiley +1 more source
Clinical characteristics and follow‐up of 77 patients with pathogenic fumarate hydratase variants
BJU International, EarlyView.
Matthijs Duijn +12 more
wiley +1 more source
Depicting the Immunological Landscape of Basal Cell Carcinoma Subtypes
ABSTRACT Background Anti‐PD‐1 response has been associated with higher PD‐1 ligand (PD‐L1) expression levels in different cancer types. Cemiplimab, an anti‐PD‐1 antibody, has been shown to induce a response rate of 31% and 22% in patients with locally advanced basal cell carcinoma (BCC) and metastatic BCC respectively, who have progressed or are ...
Isabella Dommann +9 more
wiley +1 more source
Tumour seeding and upstaging in papillary renal cell carcinoma: an uncommon complication of renal mass biopsy. [PDF]
Powell E, Lawlor P, Vivian J.
europepmc +1 more source
Uterine papillary serous carcinoma [PDF]
Zoltán, Langmár +2 more
openaire +2 more sources

